Stockreport

Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi™ (Triamcinolone Acetonide-Moxifloxacin for injection) Formulation in Canada

IMPRIMIS PHARMACEUTICALS  (IMMY) 
Last imprimis pharmaceuticals earnings: 5/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: imprimisrx.com
PDF SAN DIEGO, Aug. 1, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) through its ImprimisRx ophthalmology business today announced its Canadian partner, [Read more]